Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERACYTE, INC.VCYT · Entity 2018 | Director | September 14, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERACYTE, INC.
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,471 |
Reported balance
After 2026-09-14 transaction · row 1
1 source rowRow 1 · 2026-09-14 · Sale · Disposed 5,000 · Balance 27,471 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2026. F2: Represents weighted average sales price. Sale prices for the transactions range from $40.57 to $41.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2026.
F2: Represents weighted average sales price. Sale prices for the transactions range from $40.57 to $41.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 16, 2026 20:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 5,000 | $40.95 | $204,747.00 |
DisclosureSEC source: 0001819880-26-000004 · wk-form4_1789589284.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,471 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2026. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $40.57 to $41.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:55 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001819880-26-000002 · wk-form4_1781556948.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,471 F1 · kind: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,460 | $43.21 | $63,085.87 |
DisclosureSEC source: 0001819880-25-000005 · wk-form4_1763759939.xml · nonDerivative · entry 3 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,199 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $43.075 to $43.37. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 7,049 | $42.48 | $299,416.85 |
DisclosureSEC source: 0001819880-25-000005 · wk-form4_1763759939.xml · nonDerivative · entry 2 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,659 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $41.89 to $42.89. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,491 | $40.95 | $61,060.33 |
DisclosureSEC source: 0001819880-25-000005 · wk-form4_1763759939.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,708 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $40.86 to $41.20. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 9,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-25-000098 · wk-form4_1750709420.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,199 F1 · kind: Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 2,500 | $30.00 | $75,000.00 |
DisclosureSEC source: 0001384101-24-000122 · wk-form4_1723236472.xml · nonDerivative · entry 2 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,878 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 11, 2024. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 2,500 | $28.00 | $70,000.00 |
DisclosureSEC source: 0001384101-24-000122 · wk-form4_1723236472.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,378 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 11, 2024. Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 22:25 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 2,500 | $25.00 | $62,500.00 |
DisclosureSEC source: 0001384101-24-000109 · wk-form4_1721341505.xml · nonDerivative · entry 2 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,878 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 11, 2024. Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 22:25 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 2,500 | $24.00 | $60,000.00 |
DisclosureSEC source: 0001384101-24-000109 · wk-form4_1721341505.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,378 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 11, 2024. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 20:48 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 11,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000103 · wk-form4_1718657322.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,878 F1 · kind: Restricted stock units awarded on June 13, 2024 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:21 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 9,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-23-000123 · wf-form4_168669128164221.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,405 F1 · kind: Restricted stock units awarded on June 9, 2023 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 00:04 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 14,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-22-000088 · wf-form4_165542424124631.xml · nonDerivative · entry 2 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,731 F2 · kind: Restricted stock units awarded on June 16, 2022 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 14, 2022 Filed Jun 17, 2022 00:04 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 8,720 | $16.27 | $141,846.50 |
DisclosureSEC source: 0001384101-22-000088 · wf-form4_165542424124631.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · price: Represents weighted average sales price. Sale prices for the transactions range from $16.25 to $16.32. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 20:18 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 8,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-21-000112 · wf-form4_162335626936965.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,720 F1 · kind: Restricted stock units awarded on June 8, 2021 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 21:00 UTC | VERACYTE, INC. VCYT · Entity 2018 | PurchaseCommon Stock | 2,000 | $35.19 | $70,389.20 |
DisclosureSEC source: 0001384101-21-000098 · wf-form4_162284040266451.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · price: Represents weighted average purchase price. Purchase prices for the transactions range from $35.15 to $35.40. Detailed information regarding the number of shares purchased at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 23:49 UTC | VERACYTE, INC. VCYT · Entity 2018 | Grant35000 · Derivative | 35,000 | $0.00 Strike: $35.30 | $0.00 |
DisclosureSEC source: 0001437749-20-016553 · rdgdoc.xml · derivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2030-08-01 F1 · derivative.exercise_date: The stock option awarded on August 1, 2020 vests 1/3 on each annual anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.